Abstract. In culture, vascular smooth muscle ceils (SMC) grow in a "hill-and-valley" (multilayered) pattern of organization. We have studied the growth, behavioral organization, and biosynthetic phenotype of rat aortic SMC exposed to purified platelet-derived growth regulatory molecules. We show that multilayered growth is not a constitutive feature of cultured SMC, and that beta-type transforming growth factor (TGF-13) is the primary determinant of multilayered growth and the hill-and-valley pattern of organization diagnostic for SMC in culture. TGF-I~ inhibited, in a dose-dependent manner, the serum-or platelet-derived growth factor-mediated proliferation of these cells in two-dimensional culture, but only when cells were plated at subconliuent densities. The ability of TGF-[~ to inhibit SMC growth was inversely correlated to plating cell density. When SMC were plated at monolayer density (5 x 104 cells/cm 2) to allow maximal cell-to-cell contact, TGF-[I potentiated cell growth. This differential response of SMC to TGF-[~ may contribute to the hill-and-valley pattern of organization. Unlike its effect on other cell types, TGF-I3 did not enhance the synthesis of fibronectin or its incorporation into the extracellular matrix. However, the synthesis of a number of other secreted proteins was altered by TGF-13 treatment. SMC treated with TGF-13 for 4 or 8 h secreted markedly enhanced amounts of an Mr 38,000-D protein doublet whose synthesis is known to be increased by heparin (another inhibitor of SMC growth), suggesting metabolic similarities between heparin-and TGF-13-mediated SMC growth inhibition. The data suggest that TGF-13 may play an important and complex regulatory role in SMC proliferation and organization during development and after vascular injury.
U
'NSCHEDULED proliferation of vascular smooth muscle cells (SMC)' is an important component of the atherogenic process (25) and a major factor in the failure of a significant number of vascular r~onstructions (7, 31) . Our understanding of the factors controlling SMC growth derives, in large part, from studies of cultured cells. SMC proliferation in vitro can be stimulated by a variety of serum-derived growth factors, most notably the plateletderived growth factor (PDGF) (24) . SMC growth can be inhibited by heparin-like molecules (4, 8) or by transforming growth factor-beta (TGF-I~), a multifunctional peptide (recently reviewed by Sporn et al. [27] ) present in significant amounts in platelets (1, 2, 6, 22, 23) and synthesized by a variety of cells in culture (27) . TGF-[3 may be an important regulatory factor for SMC in vivo given its high concentration in platelets and the potential importance of platelet products in vascular pathologies.
When isolated from the tunica media and cultured in serum, vascular SMC are not strictly contact-inhibited and grow with a characteristic "hill-and-valley" morphology (5) ("hills" consist of foci of multilayered cells). In this report we show that multilayered growth is not a constitutive property 1 . Abbreviations used in this paper: PDGF, platelet-defived growth factor; SMC, smooth muscle cell(s); "I'GF-I~, beta-type transforming growth factor. of tunica media-derived cultured SMC, and present evidence that TGF-13 is the primary determinant of the hill-and-valley growth pattern of SMC in vitro. TGF-I3 exerts paradoxical control over SMC growth: as previously reported (2) and as shown herein, TGF-[I markedly inhibits the proliferation of sparsely plated SMC. At the same time, TGF-I3 specifies determinants that allow SMC to grow in multilayers, thus permitting cultures to reach markedly greater saturation densities. This effect may be related to our finding that TGF-I3 can augment the growth of SMC at high cell density. TGF-I3 was also found to regulate the SMC biosynthetic phenotype and to induce synthesis of a previously described Mr 38,000-D protein whose secretion is markedly enhanced by heparin (13) , another inhibitor of SMC growth (4, 8) . Our data suggest that TGF-I3 may play an important role in directing the organizational, proliferative, and biosynthetic behavior of SMC during development, during angiogenesis, and after injury. and 0.1 mg/ml streptomycin. Cells were maintained in an humidified 37°C, 5 % CO2 atmosphere and were utilized in the third to sixth passage. Serumfree medium (12) was prepared as a 1:1 mixture of DMEM and F12 media supplemented with 0.1 mg/ml BSA and 5 pg/ml transferrin. Cultures were photographed on a Fluovert inverted microscope (E. Leitz, Wetzlar, Federal Republic of Germany) using a ×4 or xl0 phase-contrast objective. For lowmagnification photography, cells were stained with Coomassie Blue to aid visualization.
Growth Factors
PDGF was purchased from Bethesda Research Laboratories (Gaithersburg, MD). The PDGF was purified from fresh porcine platelets and was >90% pure by silver-stained SDS-PAGE. The PDGF preparations contained <0.2 % TGF-[I. Porcine platelet TGF-13 was purchased from R&D Systems, Inc. (Minneapolis, MN), and was shown to be >96% pure by silver-stained SDS-PAGE, amino acid analysis, and NH2-terminus sequencing. The halfmaximal activity of colony formation in soft agar (28) was determined to be 1 ng/ml.
Cell Growth Assays
Cell growth assays were performed in triplicate in 16-ram wells (12-well plates). Except where noted, cells were plated at 5 x 103 cells/cm 2 in 5 % FBS and allowed to attach and spread for 24 h before addition of test medium. At the time of harvest, medium was removed, cells were washed twice in PBS, and 1.0 ml of 0.4% trypsin/EDTA was added to each well. Cell numbers were determined electronically on a model ZM Coulter counter (Coulter Electronics, Inc., Hialeah, FL). All tissue culture chemicals were obtained from Gibco (Grand Island, NY). Where data are expressed as percent inhibition of growth, values were derived according to this formula: % inhibition = [1 -(net growth of treated cells)/(net growth of control cells)] x 100, where the net growth of cells represents the difference between the plating density and the final cell density.
SDS-PAGE
SMC were grown in 5% FBS in 35-mm diam tissue culture wells and were treated with 10 ng/ml TGF-13 as indicated. Metabolic labelings were performed by culturing cells for 2 h in serum-free medium lacking methionine in the presence of 50 pCi/ml [35S]methionine (New England Nuclear, Boston MA). Radiolabeled culture medium proteins were harvested into protease inhibitors at 4°C to yield a final concentration of 25 mM EDTA, 1 mM N-ethylmaleimide, 45 pg/mi pepstatin, and 0.9 mM phenylmethylsulfonyl fluoride. Proteins were precipitated in 10% trichloroaeetic acid, dissolved in SDS-PAGE sample buffer containing 50 mM dithiothreitol, and resolved on 6% or 10% polyacrylamide gels. Cell layer proteins were washed twice with PBS, lysed in 95"C sample buffer containing 50 mM dithiothreitol, and resolved on 6% or 10% polyacrylamide gels. Gels were fixed, dried, and exposed to film at -70°C. The position of migration of fibronectin was determined by immunoprecipitation as described (15) . Molecular mass estimates were derived from comparisons with the positions of migration of known molecular mass standards. 
Results

Growth Kinetics and Morphologic Organization of SMC Cultured in Serum or PDGF
SMC proliferate in culture in response to FBS or in response to appropriate purified growth factors in the presence of ~main-tenance" levels of serum or plasma. Cells become quiescent if maintained in serum-free medium or in 0.5% FBS for periods of 48-72 h (15, 16) . However, in the additional presence of 10 ng/ml PDGF (sufficient to elicit a substantial mitogenic response [16] ), proliferation continues albeit at a slower rate than for SMC maintained in FBS (Fig. 1 ). SMC grown in low serum and PDGF reached saturation densities of 1-2 x 105 cells/cm 2, whereas cells grown in FBS reached threefold greater densities (5 x 105 cells/cm2). The morphologic appearance, at confluency, of cultures grown under these conditions is presented in Fig. 2 . As shown, cells cultured in FBS grew to overconfluence and organized into the hill-and-valley pattern characteristic of vascular SMC in culture. In contrast, SMC maintained in 0.5% FBS and PDGF reached only monolayer density and never exhibited multilayered growth. We conclude that multilayered growth is not a constitutive feature of vascular SMC in vitro, and that a factor in serum, other than PDGF, is the primary determinant of this growth pattern. We have investigated the possibility that this determinant is TGF-I3.
Effects of TGF-[3 on SMC Growth and Organization in Culture
As shown previously (2), TGF-13 is a potent inhibitor of bovine aortic SMC growth in vitro, when given in concert with 5 % FBS or in platelet-poor plasma supplemented with epidermal growth factor (EGF). We have used a 4-d cell number assay (described in Materials and Methods) to assess the effects of increasing amounts of TGF-[i on the proliferation of SMC prepared from the rat aorta. TGF-[i was found to be a potent inhibitor of SMC proliferating in response to 5 % FBS (not shown) or 0.5% FBS supplemented with 10 ng/ml PDGF (Fig. 3) , with a half-maximal effect observed at concentrations <1 ng/ml. A maximal effect (>70% inhibition) was seen at concentrations >110 ng/ml (Fig. 3) . TGF-[i did not stimulate SMC proliferation when added alone (at 10 ng/ml) to cells maintained in 0.5% FBS. The morphologic appearance of control and TGF-~-inhibited cells was determined, as part of our dose-response assays (Fig. 3) , on day 4. As shown in Fig. 4 a, control cells (proliferating in response to PDGF alone) grew to a monolayer and exhibited a "cobblestone" pattern of organization. In contrast, TGF-13-treated SMC organized into multilayered foci concomitant with a markedly reduced final cell density Note that TGF-13-treated SMC show marked growth inhibition. ( Fig. 4 b) . In the dose-response assays, inhibition of SMC growth by TGF-13 correlated with the ability of the cultures to form multilayers.
Organizational Behavior of SMC in Response to PDGF and TG F-[3
To further investigate the effects of TGF-I~ on multilayered growth of SMC, we studied the organizational behavior of SMC maintained in a defined media (12) , to eliminate possible combinatorial effects of TGF-I~ with factors present in 0.5% FBS. After a 48-h incubation in defined medium, growth factors were added singly or in combination, and organizational morphologies were examined at subconfluent or confluent densities. We have previously shown that the defined medium used for these experiments is sufficient to support the mitogenic response of SMC to PDGF (16) . As shown in Fig. 5 , SMC maintained in defined medium supplemented with PDGF and/or TGF-13 exhibited different organizational behaviors. After 4-8 d of serum-free culture, SMC appeared randomly dispersed on the culture surface; cells were moderately spread and ovoid rather than spindleshaped (not shown). In contrast, cells treated with TGF-13 alone were not randomly distributed over the culture dish but instead were organized into "fascicles" of cells, often with the outermost cells aligned circumferentially around the perimeter of the fascicle, enclosing an innermost group of randomly oriented cells (Fig. 5 a) . Typically, this type of organizational behavior was observed within 4 d after addition of TGF-13. Cells maintained in TGF-13 did not proliferate and did not reach confluent densities. SMC treated with PDGF alone appeared, at sparse density, as randomly spread, individual cells with a more spindle-shaped morphology (not shown). At confluence, PDGF-treated cells exhibited a monolayered, "cobblestone" pattern ( Fig. 5 b) , identical to that illustrated above (Fig. 2 a) for SMC proliferating in PDGF Figure 5 . Organizational behavior of SMC exposed to PDGF and/or TGF-13 under serum-free conditions. SMC were plated in 5 % FBS at 5 X 103 cells/cm ~ in 35-mm wells, allowed to attach for 24 h, then incubated in serum-free medium for 48 h (see text for details). Cells were then exposed to 10 ng/ml PDGF and/or 10 ng/ml TGF- and 0.5% FBS. When SMC were treated with PDGF and TGF-13 in concert, cells appeared more elongate and aggregated into multilayered foci, even at low density (Fig. 5,  c and d) . In confluent areas of the cultures, cells organized into distinct multilayered nodules and exhibited the hill-andvalley organization diagnostic for SMC in culture (Fig. 5 e) . We therefore conclude, on the basis of these data, that TGF-I3 specifies the multilayered pattern of growth of cultured aortic SMC.
Differential Effects of TGF-fl on SMC Proliferation
To explain the apparent paradox between the ability of TGF-13 to inhibit the growth of SMC cultures while simultaneously promoting the formation of multilayered nodules, we hypothesized that TGF-13 may exert differential, density-dependent effects on SMC proliferation. To test this possibility, SMC were plated at l x 103 , 5 x 103 ,1 x 104 , o r 5 x 104 cells/cm 2 in either 16-mm wells (for growth studies) or in 35-mm wells (for morphologic studies). Cells were grown in 5 % FBS in the absence or presence of 10 ng/ml TGF-IL As presented in Fig. 6 , TGF-13 was a potent inhibitor of the growth of sparsely plated SMC. However, as plating density increased, the efficacy of TGF-13 as a growth inhibitor was decreased. The proliferation of cells plated at monolayer density (5 x 104 cells/cm 2) was augmented by TGF-I~. The morphologic appearance of SMC cultures after TGF-I$ treatment under these conditions is also presented in Fig. 6 . These data, which imply a selective ability of TGF-13 to stimulate the growth of cells already in aggregated conditions (in close contact with their neighbors), suggest a plausible mechanism by which TGF-13 may promote the hill-and-valley pattern of organization.
Effects of TGF-~ on the SMC Biosynthetic Phenotype
Previous studies that used other cell types (11, 23) have suggested that TGF-[I may exert certain of its growth-regulatory effects via enhancement of fibronectin synthesis. Fibronectin has also been implicated in the formation of "nodules" in cultures of vascular SMC (3). These observations led us to investigate a possible role for fibronectin in the TGF-13-mediated effects described above. First, we used metabolic labeling techniques to determine comparative levels of fibronectin synthesis in control and TGF-13-treated SMC. Control cells and cells treated with 10 ng/ml TGF-13 for 0--46 h were metabolically labeled for 2 h with [3SS]methionine in the continued presence of TGF-[~. Radiolabeled secreted and cell layer proteins were resolved by SDS-PAGE and visualized by autoradiography. No significant increase was noted in fibronectin synthesis (identified by specific immunoprecipitation) at any time point studied (Fig. 7) . We also employed immunofluorescence techniques to detect possible differences in the distribution of fibronectin in control vs. TGF-13-treated SMC. SMC were cultured in 0.5 % FBS supplemented with 10 ng/ml TGF-13, 10 ng/ml PDGF, or both factors for 72 h, then were fixed and stained with a goat antibody to rat fibronectin as previously described (14) . No differences were observed in the distribution of fibronectin in the SMC matrix or on the cell surface under these three conditions. We predict that the TGF-13-mediated morphologic changes described above are due to determinants other than fibronectin. Fig. 7 presents an SDS-PAGE analysis of the SMC biosyn- Figure 6 . Differential effects of TGF-I) on SMC growth as a function of cell density. SMC were plated in 5% FBS at the indicated densities and allowed to attach for 24 h. On day 0 (24 h after plating), cell numbers were determined and cultures were exposed to either fresh 5% FBS or to 5% FBS supplemented with 10 ng/ml TGF-I~. Cell numbers were determined at day 3 and the percent inhibition or stimulation of growth was determined as described in Materials thetic phenotype after treatment of cells with TGF-13 for 0, 2, 4, 8, or 24 h. No differences in protein synthesis were detected in cell layer samples; these data are not presented. Several differences in the relative production of secreted proteins were noted. We observed selective increases in proteins with M, 90,000, 38,000, and 22,000 D and a decrease in proteins with M, 92,000 and 55,000 D. These proteins are of particular interest in view of the regulation of their production in other culture conditions. For example, PDGF treat- (13), another inhibitor of SMC growth (4, 8) . Synthesis of the Mr 38,000-D protein doublet was not increased above controls after 24 or 48 h of exposure to TGF-13, despite the maintenance of other TGF-13-mediated biosynthetic changes at these time points.
Discussion
In culture, vascular SMC exhibit a characteristic "hill-andvalley" pattern of organization. This growth pattern has been extensively described in SMC cultures derived from a variety of species (5, 9, 30) and is considered a diagnostic feature of these cells in culture (5) . In this report we show that the ability to organize into multilayers is not a constitutive feature of SMC in vitro. Rather, multilayered growth appears to be specified by the response of these cells to TGF-13, a recently described regulatory peptide that controls the growth and differentiation of a variety of cell types (10, 18, 19, 27) . TGF-I~ is found in platelets (1, 2, 6, 22, 23) in concentrations roughly equivalent to that of PDGF (1) . The effects of TGF-13 on arterial SMC function may therefore be of considerable importance in vascular biology given the probable involvement of platelet products in atherogenesis, wound healing, and other vessel wall pathologies (25) . Our data suggest that TGF-13 may regulate a number of SMC functions including proliferation (2), behavioral organization, and biosynthetic phenotype.
The formation and maintenance of contact-inhibited monolayer cultures has, until recently, been considered a feature exclusive (among vascular cells) to cultured endothelium. Although clonal variability in organizational behavior of cultured SMC has been described (17), Walker et al. (29) have recently provided one example of a population of SMC that exhibits monolayered growth. In their studies, phenotypically distinct SMC populations were cultured from the intima and media of carotid arteries after injury. Intimal-derived SMC secreted increased amounts of PDGF-like molecules, possessed fewer PDGF receptors, and exhibited a "cobblestone" monolayer growth pattern similar to that of aortic media-derived SMC proliferating in response to PDGF alone (Figs. 2 and 4) . Similar results have been described by Seifert et al. (26) for neonatal SMC. The data imply that an additional characteristic of neointimal or neonatal SMC proliferating in vivo may be a lack of responsiveness to TGF-13, a possibility which is currently being investigated. Multilayered growth therefore does not appear to be a constitutive feature of cultured arterial SMC. Rather, the organizational behavior of SMC in culture may vary according to the type of growth-regulatory molecules presented to the cells. The tendency to exhibit multilayered growth undoubtedly reflects an ability of TGF-I3 to differentially regulate SMC growth as well as an increased ability of SMC to interact, in a nonpolarized fashion, with all surfaces of its neighboring cells. This ability may be an important requisite for the formation of three-dimensional structures at appropriate time points during development or tissue repair.
In other cell systems (11, 23) , TGF-I3 appears to exert its growth-regulatory effects via stimulation of synthesis of fibronectin, a ubiquitous cell surface and extracellular matrix protein. SMC treated with TGF-I3 for up to 48 h showed no alteration in fibronectin synthesis or cell surface distribution of immunoreactive protein. Although our data cannot rule out subtle molecular alterations in fibronectin structure, we predict that the effects of TGF-13 on SMC growth and behavioral organization are mediated by a determinant other than fibronectin.
Other effects of TGF-I3 on the SMC biosynthetic phenotype were observed in our studies. Of particular interest is the TGF-13-mediated increase in synthesis of a secreted Mr 38,000-D protein. This protein appears identical to an Mr 38,000-D protein whose synthesis and secretion is markedly enhanced by treatment of rat SMC with heparin (13), a potent inhibitor of SMC migration (14) , and proliferation (4, 8) . The characteristics of regulation of this protein by heparin have been fully described (13) . In contrast to the very rapid induction of secretion of this protein by heparin (13) , enhanced production of the Mr 38,000-D protein w'.-s not ob-served until 4 h of treatment with TGF-13. Nevertheless, the data suggest a common metabolic relationship between the mechanisms of heparin-and TGF-13-mediated growth inhibition. Finally, the Mr 38,000-D protein may relate to a protein of similar size secreted by swine aortic SMC after formation of"nodules" (multilayered aggregates) in culture (20, 21) . Our data predict potentially important relationships among TGF-13, SMC growth inhibition in general, the formation of multilayered aggregates ("nodules") of SMC, and expression of an Mr 38,000-D secreted protein.
